Abdala demonstrates safety and immunogenicity in children
Clinical trials of Cuba’s anti-COVID-19 vaccine Abdala, successfully administered to millions of adults, indicate that it is safe and effective in pediatric age groups
Author: National news staff | informacion@granma.cu
february 17, 2022 10:02:47



